AG-AMOXI CLAV

d. d. regimen (see 8 ADVERSE REACTIONS). D. D. 25 mg clavulanic acid per 5 mL for oral suspension*** AG-Amoxi Clav Suspension -250 Otitis Media** 40 mg/kg/day in divided doses every 8 hours * The bid regimen is recommended as it is associated with significantly less diarrhea.

**Duration of therapy studied and recommended for acute otitis media is 10 days. 25 mg clavulanic acid The normal duration of treatment was 7 to 10 days. However, in general, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained.

It is recommended that there be at least 10 days treatment for any infection caused by β-hemolytic streptococci to prevent the occurrence of acute rheumatic fever or glomerulonephritis. The children's dosage should not exceed that recommended for adults.

Children weighing more than 38 kg should be dosed according to the adult recommendations. 25 mg clavulanic acid per 5 mL for oral suspension or AG-Amoxi Clav Suspension -250) according to body weight. 1 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid.

25 mg clavulanic acid per 5 mL for oral suspension and AG-Amoxi Clav Suspension-250. 25 mg clavulanic acid per 5 mL for oral suspension or ten (10) mL of reconstituted AG-Amoxi Clav Suspension -250 oral suspension are equivalent to one (1) amoxicillin and clavulanate potassium-500 mg /125 mg tablet.

Table 2 below may be used as a guide to determine the dosage of oral suspension (AG-Amoxi Clav Suspension -200 or AG-Amoxi Clav Suspension -400) according to body weight. 7 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid.

These two ingredients are in a ratio of 7:1 in both oral suspensions, AG-Amoxi Clav Suspension-200 and AG- Amoxi Clav Suspension-400. A calibrated dropper should be used to measure the appropriate volume for dosing. Pediatrics (Neonates and children […]

). D. D. 25 mg clavulanic acid per 5 mL for oral suspension*** AG-Amoxi Clav Suspension -250 Otitis Media** 40 mg/kg/day in divided doses every 8 hours * The bid regimen is recommended as it is associated with significantly less diarrhea.

**Duration of therapy studied and recommended for acute otitis media is 10 days. 25 mg clavulanic acid The normal duration of treatment was 7 to 10 days. However, in general, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained.

It is recommended that there be at least 10 days treatment for any infection caused by β-hemolytic streptococci to prevent the occurrence of acute rheumatic fever or glomerulonephritis. The children's dosage should not exceed that recommended for adults.

Children weighing more than 38 kg should be dosed according to the adult recommendations. 25 mg clavulanic acid per 5 mL for oral suspension or AG-Amoxi Clav Suspension -250) according to body weight. 1 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid.

25 mg clavulanic acid per 5 mL for oral suspension and AG-Amoxi Clav Suspension-250. 25 mg clavulanic acid per 5 mL for oral suspension or ten (10) mL of reconstituted AG-Amoxi Clav Suspension -250 oral suspension are equivalent to one (1) amoxicillin and clavulanate potassium-500 mg /125 mg tablet.

Table 2 below may be used as a guide to determine the dosage of oral suspension (AG-Amoxi Clav Suspension -200 or AG-Amoxi Clav Suspension -400) according to body weight. 7 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid.

These two ingredients are in a ratio of 7:1 in both oral suspensions, AG-Amoxi Clav Suspension-200 and AG- Amoxi Clav Suspension-400. A calibrated dropper should be used to measure the appropriate volume for dosing. Pediatrics (Neonates and children aged <12 weeks (3 months)) Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended dose of AG-Amoxi Clav Suspension is 30 mg/kg/day divided q12h, based on the amoxicillin component.

, Hepatic/Biliary/Pancreatic. 2 CONTRAINDICATIONS AG-Amoxi Clav Suspension is contraindicated in patients: • with a history of hypersensitivity to the penicillin, or cephalosporin group of β- lactams, or to any ingredients contained in the preparation or component of the container.

For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AG-Amoxi Clav Suspension (Amoxicillin and Clavulanate Potassium for Oral Suspension) Page 5 of 43 AND PACKAGING. • where infectious mononucleosis is either suspected or confirmed.

• with a previous history of amoxicillin and clavulanate potassium-associated jaundice/hepatic dysfunction. 3 SERIOUS WARNINGS AND PRECAUTIONS BOX Serious Warnings and Precautions • Hypersensitivity: Serious and occasionally fatal hypersensitivity (anaphylactic) and severe cutaneous adverse reactions (SCAR) have been reported in patients receiving therapy with beta-lactams, including amoxicillin.

See 7 WARNINGS AND PRECAUTIONS, Hypersensitivity Reactions and 7 WARNINGS AND PRECAUTIONS, Skin. d. d. regimen (see

AG-Amoxi Clav Suspension is contraindicated in patients: • with a history of hypersensitivity to the penicillin, or cephalosporin group of β- lactams, or to any ingredients contained in the preparation or component of the container.

For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AG-Amoxi Clav Suspension (Amoxicillin and Clavulanate Potassium for Oral Suspension) Page 5 of 43 AND PACKAGING. • where infectious mononucleosis is either suspected or confirmed.

• with a previous history of amoxicillin and clavulanate potassium-associated jaundice/hepatic dysfunction.